BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2020
View Archived Issues
Autophagy linked to neurotransmission
Read More
A promising multitarget antipsychotic among piperidine-amide substituted derivatives
Read More
Immuron reports new data on vaccine targeting Campylobacter and ETEC
Read More
Arcturus reports interim data from phase I/II study of COVID-19 vaccine candidate ARCT-021
Read More
Gilead Sciences patents HIV protease inhibitors
Read More
Aligos Therapeutics divulges new compounds for hepatitis
Read More
Vivace Therapeutics synthesizes YAP1/TEAD interaction inhibitors
Read More
LIfT BioSciences reports in vivo data on N-LIfT for pancreatic cancer
Read More
GBiotech Sarl presents new FFAR1 agonists
Read More
Chinese researchers discover EpCAM-targeting antibodies
Read More
hAd5-COVID-19 stimulates memory T-cell recall in previously infected COVID-19 patients
Read More
First patient dosed in phase I study of NTLA-2001 in hATTR-PN
Read More
Researchers develop a new Ptpn14-knockout murine model of HHT
Read More
European Commission approves Calquence for the treatment of CLL
Read More
Study shows how mutant KRAS initiates pancreatic cancer
Read More
Preclinical characterization of [99mTc]Tc-TECANT-1
Read More
[125I]PIB-Ec1 as promising tracer for imaging EpCAM expression in ovarian cancer
Read More
Phase III NAVIGATOR study of tezepelumab in severe asthma meets primary endpoint
Read More
GlaxoSmithKline's RSVPreF3 candidate vaccine shows promising clinical results
Read More
Arena reports topline phase IIb results with etrasimod in atopic dermatitis
Read More
New phase Ib/IIa trial examines Immunophotonics' IP-001 in thermally ablated solid tumors
Read More
FDA issues EUA for Lilly's bamlanivimab to treat recently diagnosed COVID-19
Read More
Phase I/II data with PKU gene therapy HMI-102 show marked reductions in Phe at two doses
Read More
Phase III CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint
Read More
FDA approves Totect to treat cardiomyopathy in women receiving doxorubicin for breast cancer
Read More
Sorrento files IND for STI-2020 for treatment of COVID-19
Read More
FDA issues complete response letter for SPN-812 for ADHD
Read More